Curated News
By: NewsRamp Editorial Staff
September 11, 2026
Nanox Expands to Costa Rica with Nanox.ARC Distribution Deal
TLDR
- Nanox expands into Costa Rica via SOLME, its third Latin American market this year, gaining CCSS supplier access for the Nanox.ARC.
- Nanox.ARC commercialization in Costa Rica requires initial six-month proof-of-concept device registration before full regulatory registration, with SOLME handling distribution and support.
- Nanox.ARC aims to expand access to 3D medical imaging in Costa Rica, enabling earlier detection and improved patient outcomes through affordable technology.
- Nanox.ARC is a multi-source digital tomosynthesis system that offers cost-effective 3D imaging for easier and scalable medical use.
Impact - Why it Matters
This distribution agreement marks a significant step in Nanox's mission to make advanced medical imaging more accessible and affordable globally. By entering Costa Rica, Nanox not only expands its presence in Latin America but also demonstrates the scalability and appeal of its integrated imaging platform. The Nanox.ARC, with its cost-effective 3D tomosynthesis technology, has the potential to enhance early disease detection and improve patient outcomes in regions where access to such technology is limited. This move could accelerate the adoption of preventive care and set a precedent for similar agreements in other emerging markets, ultimately contributing to better healthcare infrastructure worldwide.
Summary
Nanox (NASDAQ: NNOX), a company dedicated to driving the world's transition to preventive health care through an integrated medical imaging platform, has announced a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor. The collaboration aims to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. Under the agreement, SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This marks Nanox's third Latin American market this year, following Argentina and Peru, signaling the company's growing footprint in the region.
The Nanox.ARC is part of a broader ecosystem that includes Nanox.AI, a suite of AI-based algorithms for CT imaging; Nanox.CLOUD, a cloud-based platform for secure data management and advanced analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and secure infrastructure solutions. By integrating affordable imaging hardware, AI, cloud infrastructure, and clinical expertise, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX.
For full details, view the original release on www.newmediawire.com.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, Nanox Expands to Costa Rica with Nanox.ARC Distribution Deal
